- Provides essential and non-essential amino acids for the prophylactic or therapeutic treatment of protein depletion, where sufficient enteral feeding is impossible or impracticable
- Can be used in infants at the physician's discretion. An amino acid solution containing larger amounts of cysteine/cystine and tyrosine may be more appropriate in infants. When used in children below 2 years, the solution (in bags and administration sets) should be protected from light exposure until administration is completed
- Electrolyte-free formulation
- Extensive compatibility and stability data with parenteral nutrition regimens are available upon request from our medical information team: Medical.Information-UK@fresenius-kabi.com
Vamin® 14 Electrolyte-Free
(amino acids)
- Filename
- Macronutrient Prescribing Information.pdf
- Size
- 209 KB
- Format
Details
- Benefits
- Composition
- Indication
- Presentation and order codes
| Contents per 1000ml | |
|---|---|
| Nitrogen | 13.5g |
| Amino acids | 85g |
| Energy | 350kcal |
Values are approximate
For the prophylactic or therapeutic treatment of protein depletion when sufficient enteral feeding is impossible or impractical.
| Vamin® 14 EF | ||
|---|---|---|
| Unit size | Case qty | Ordering code |
| 500ml | 10 | 3018091 |
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk Adverse events should also be reported to Fresenius Kabi Limited. Email: Pharmacovigilance.GB@fresenius-kabi.com
GB-Vam-2400005 January 2025